Clifton, NJ, United States of America

Xianqing Shi


Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Clifton, NJ (US) (2012 - 2016)
  • Morris Plains, NJ (US) (2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Xianqing Shi: Innovator in Pharmaceutical Chemistry

Introduction

Xianqing Shi is a notable inventor based in Clifton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the synthesis of novel compounds that have potential therapeutic applications.

Latest Patents

Xianqing Shi's latest patents include a compound known as (3,4-dichloro-phenyl)-((S)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride, which is associated with a novel process for its preparation and its hydrates. This compound is recognized as a pharmaceutically active substance. Another significant patent involves the synthesis of amino-methyl tetralin derivatives, detailing methods for producing specific compounds through the reduction of dihydronapthalene amide compounds using hydrogen gas in the presence of a ruthenium catalyst.

Career Highlights

Throughout his career, Xianqing Shi has worked with prominent companies in the pharmaceutical industry, including Roche Palo Alto LLC and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing innovative chemical processes.

Collaborations

Xianqing Shi has collaborated with notable professionals in his field, including Justin Philip Vitale and Kieran Durkin. These collaborations have likely enhanced his research and development efforts.

Conclusion

Xianqing Shi is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important compounds and processes. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…